Pharmacovigilance of artemether-lumefantrine in pregnant women followed until delivery in Rwanda

Malaria Journal

Volumn 11, Issue , 2012, Pages

  Rulisa, Stephen ^a,b   Kaligirwa, Nadine ^c   Agaba, Steven ^c   Karema, Corine ^c   Mens, Petra F ^b,d   De Vries, Peter J ^b  

^a UNIVERSITY OF RWANDA   (Rwanda)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c RWANDA BIOMEDICAL CENTER   (Rwanda)

^d ROYAL TROPICAL INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL; QUININE; ANTIMALARIAL AGENT; ARTEMISININ DERIVATIVE; ETHANOLAMINE DERIVATIVE; FLUORENE DERIVATIVE;

ABORTION; ADOLESCENT; ADULT; ADVERSE OUTCOME; ARTICLE; BRAIN HYPOXIA; CONGENITAL MALFORMATION; CONTROLLED STUDY; DRUG SURVEILLANCE PROGRAM; DRUG TREATMENT FAILURE; FEMALE; FETUS DISTRESS; HUMAN; HYDROCEPHALUS; MAJOR CLINICAL STUDY; MALARIA; MORTALITY; NEWBORN INFECTION; NEWBORN MORTALITY; PERINATAL PERIOD; PREGNANCY OUTCOME; PREGNANT WOMAN; PREMATURE LABOR; PRENATAL PERIOD; PRIMIGRAVIDA; STILLBIRTH; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; COHORT ANALYSIS; DRUG COMBINATION; DRUG TOXICITY; MIDDLE AGED; PREGNANCY; PREGNANCY COMPLICATION; RWANDA;

ADOLESCENT; ADULT; ANTIMALARIALS; ARTEMISININS; COHORT STUDIES; DRUG COMBINATIONS; DRUG TOXICITY; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA; MIDDLE AGED; PHARMACOVIGILANCE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RWANDA; YOUNG ADULT;

EID: 84863431574     PISSN: None     EISSN: 14752875     Source Type: Journal    
DOI: 10.1186/1475-2875-11-225     Document Type: Article

References (22)

1. Government of Rwanda (GOR), Rwanda National Health Sector Policy -2005 GOR 2005 http://www.eac.int/health/index.php?option=com-docman&Itemid=47, Accessed 1 October 2011
2. WHO, WHO Guidelines for the Treatment of Malaria World Health Organization, Geneva Second 2010
3. Artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria. Ehrhardt S, Meyer CG, Ther Clin Risk Manag 2009 5 805 815 19851528
4. The clinical efficacy of artemether/lumefantrine (Coartem). Makanga M, Krudsood S, Malar J 2009 8 Suppl 1 5 10.1186/1475-2875-8-S1-S5 19917075
5. Safety profile of Coartem: the evidence base. FalaDe C, Manyando C, Malar J 2009 8 Suppl 1 6 10.1186/1475-2875-8-S1-S6 19917076
6. TDR, Assessment of the safety of Artemisinin compounds in pregnancy TDR 2006 http://whqlibdoc.who.int/publications/2007/9789241596114-eng.pdf, Accessed 10 March 2012
7. The safety of artemisinins during pregnancy: a pressing question. Dellicour S, Hall S, Chandramohan D, Greenwood B, Malar J 2007 6 15 10.1186/1475-2875-6-15 17300719
8. FDA, Nonclinical Safety Studies for the Conduct of Human Clinical Trials and Marketing Authorization for Pharmaceuticals FDA 2008 http://www.fda.gov/ downloads/RegulatoryInformation/Guidances/ucm129524.pdf, Accessed 31 January 2012
9. UNAIDS/WHO, Ethical considerations in biomedical HIV prevention trials: UNAIDS/WHO guidance document 2007 http://data.unaids.org/pub/manual/2007/jc1349- ethics-2-11-07-en.pdf, Accessed 15 May 2012
10. EMEA, Guideline on the exposure to medicinal products during pregnancy: need for post-authorisation data EMEA 2005 http://www.ema.europa.eu/docs/en-GB/ document-library/Regulatory-and-procedural-guideline/2009/11/WC500011303.pdf, Accessed 3 June 2012
11. Developmental toxicity of artesunate and an artesunate combination in the rat and rabbit. Clark RL, White TE, CloDe A, Gaunt I, Winstanley P, Ward SA, Birth Defects Res B Dev Reprod Toxicol 2004 71 380 394 10.1002/bdrb.20027 15617018 (Pubitemid 40076263)
12. Effects of the antimalarial drug dihydroartemisinin (DHA) on rat embryos in vitro. Longo M, Zanoncelli S, Manera D, Brughera M, Colombo P, Lansen J, Mazue G, Gomes M, Taylor WR, Olliaro P, Reprod Toxicol 2006 21 83 93 10.1016/j.reprotox.2005.05.005 16026965 (Pubitemid 43048778)
13. Artemisinin-based combination treatment of falciparum malaria. Nosten F, White NJ, AmJTrop Med Hyg 2007 77 181 192
14. Pregnancy exposure registries for assessing antimalarial drug safety in pregnancy in malaria-endemic countries. Dellicour S, ter Kuile FO, Stergachis A, PLoS Med 2008 5 187 10.1371/journal.pmed.0050187 18788893
15. Windows of achievement for six gross motor development milestones. WHO Multicentre Growth Reference Study Group. WHO Motor Development Study, Acta Paediatrica Supplement 2006 450 86 95 16817682
16. The burden of malaria in pregnancy in malaria-endemic areas. Steketee RW, Nahlen BL, Parise ME, Menendez C, AmJTrop Med Hyg 2001 64 28 35 (Pubitemid 32552569)
17. Malaria in pregnancy. Whitty CJ, Edmonds S, Mutabingwa TK, BJOG 2005 112 1189 1195 10.1111/j.1471-0528.2005.00714.x 16101595 (Pubitemid 43960913)
18. A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated Plasmodium falciparum treatment in pregnancy. McGready R, Tan SO, Ashley EA, Pimanpanarak M, Viladpai-Nguen J, Phaiphun L, Wustefeld K, Barends M, Laochan N, Keereecharoen L, PLoS Med 2008 5 253 10.1371/journal.pmed.0050253 19265453
19. Efficacy and safety of artemether-lumefantrine compared with quinine in pregnant women with uncomplicated Plasmodium falciparum malaria: an open-label, randomised, non-inferiority trial. Piola P, Nabasumba C, Turyakira E, Dhorda M, Lindegardh N, Nyehangane D, Snounou G, Ashley EA, McGready R, Nosten F, Lancet Infect Dis 2010 10 762 769 10.1016/S1473-3099(10)70202-4 20932805
20. Safety of artemisinins during early pregnancy, assessed in 62 Sudanese women. Adam I, Elhassan EM, Omer EM, Abdulla MA, Mahgoub HM, Adam GK, Ann Trop Med Parasitol 2009 103 205 210 10.1179/136485909X398285 19341535
21. Safety of artemether-lumefantrine in pregnant women with malaria: results of a prospective cohort study in Zambia. Manyando C, Mkandawire R, Puma L, Sinkala M, Mpabalwani E, Njunju E, Gomes M, Ribeiro I, Walter V, Virtanen M, et al. Malar J 2010 9 249 10.1186/1475-2875-9-249 20809964
22. National Malaria Control Programme (NMCP) -Rwanda, Integrated Approach to Reducing Malaria Related Morbidity and Mortality in Rwanda NMCP 2008 www.afro.who.int/index.php?option=com-docman&task, Accessed 12 December 2011